Kathryn E. Wengel - Mar 25, 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Director
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kathryn E. Wengel
Stock symbol
LH
Transactions as of
Mar 25, 2022
Transactions value $
$0
Form type
4
Date filed
3/29/2022, 09:47 AM
Previous filing
Feb 17, 2022
Next filing
Jun 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +603 603 Mar 25, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -603 -44.83% $0.00 742 Mar 25, 2022 Common Stock 603 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 The Restricted Stock Units vested fully on March 25, 2022.
F3 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.